Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade, Published online: 17 December 2018; doi:10.1038/s41586-018-0768-9
Deletion of the A-to-I double-stranded RNA-editing enzyme ADAR1 sensitizes tumour cells to immunotherapy.
from A via a.sfakia on Inoreader https://ift.tt/2S4JP4n
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,